Skip to content

Artificial Intelligence-assisted Glaucoma Screening (AIAGS)

The Development of Artificial Intelligence-assisted Glaucoma Screening Program

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03682783
Enrollment
8000
Registered
2018-09-25
Start date
2018-10-01
Completion date
2021-10-30
Last updated
2018-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma Eye

Keywords

Artificial Intelligence; Glaucoma

Brief summary

This study will develop an artificial intelligence (AI) program for the screening of glaucoma.

Detailed description

We have realized that the glaucomatous optic neuropathy is irreversible. But if early detection and early intervention can be performed to control the development of the disease, it can greatly reduce the blindness rate of glaucoma, improve the life quality and physiological and mental health of patients, and alleviate the social burden. Therefore, screening and early diagnosis of glaucoma is the focus of glaucoma prevention. China has a population of 1.3 billion, which greatly increase the difficulty of disease screening. In recent years, the intersection of artificial intelligence (AI) technology and modern medicine has made efficient and rapid disease screening possible.

Interventions

DIAGNOSTIC_TESTFundus Image

Fundus image of optic nerve

Sponsors

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* able to complete fundus images

Exclusion criteria

* unable to complete fundus images

Design outcomes

Primary

MeasureTime frameDescription
The specificity of the algorithm for diagnosing glaucomafrom January 2020 to March 2021The specificity of the algorithm for diagnosing glaucoma will be calculated ...
The sensitivity of the algorithm for diagnosing glaucomafrom January 2020 to March 2021The sensitivity of the algorithm for diagnosing glaucoma will be calculated .

Countries

China

Contacts

Primary ContactHaiyan Wang, Ph.D.
catherinecnc81@126.com+86 15000096256
Backup ContactKun Liu, Ph.D.
drliukun@sjtu.edu.cn+86 36126112

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026